ClearPoint Neuro (CLPT) Net Income Growth (3y) (2014 - 2026)
ClearPoint Neuro (CLPT) Net Income Growth (3y) (2014 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.88 Bn | 176.59 Bn | 6.27 Bn | -6.51% |
| 2 | Stryker | 128.94 Bn | 126.06 Bn | 3.81 Bn | 7.96% |
| 3 | Medtronic | 108.75 Bn | 99.53 Bn | 6.41 Bn | 1.93% |
| 4 | Boston Scientific | 68.65 Bn | 67.19 Bn | 3.61 Bn | 62.29% |
| 5 | Edwards Lifesciences | 48.22 Bn | 44.55 Bn | 1.29 Bn | - |
| 6 | Dexcom | 28.43 Bn | 27.31 Bn | 750.30 Mn | 60.12% |
| 7 | GE HealthCare Technologies | 28.32 Bn | 26.03 Bn | 1.98 Bn | 2.38% |
| 8 | Smith & Nephew | 26.91 Bn | 26.33 Bn | - | - |
| 9 | Koninklijke Philips | 25.10 Bn | 21.98 Bn | 2.07 Bn | 280.49% |
| 10 | ClearPoint Neuro | 427.54 Mn | 391.95 Mn | 7.76 Mn | 4.73% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 4.73% |
| Dec 31, 2025 | -18.66% |
| Sep 30, 2025 | 18.90% |
| Jun 30, 2025 | 26.47% |
| Mar 31, 2025 | 19.06% |
| Dec 31, 2024 | -4.97% |
| Sep 30, 2024 | 36.18% |
| Jun 30, 2024 | 37.81% |
| Mar 31, 2024 | 44.07% |
| Dec 31, 2023 | -25.63% |
| Sep 30, 2023 | -7.96% |
| Jun 30, 2023 | -68.60% |
| Mar 31, 2023 | -64.55% |
| Dec 31, 2022 | -41.25% |
| Sep 30, 2022 | -114.22% |
| Jun 30, 2022 | -111.49% |
| Mar 31, 2022 | -107.97% |
| Dec 31, 2021 | -29.81% |
| Sep 30, 2021 | -136.14% |
| Jun 30, 2021 | -113.45% |